Plain-English translation of NCT07441395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can safely reduce the symptoms of moderate to severe eczema (atopic dermatitis). About 200 people will take either the medication at different doses or a placebo (a pill with no active medicine) for 12 weeks. The study doctors will carefully track how the medication affects your skin and watch for any side effects.
Many people with moderate to severe eczema struggle to control their symptoms with current treatments. This medication represents a new approach that researchers hope could provide better relief and improve quality of life for those living with this frustrating skin condition.
You likely qualify if…
You likely don't qualify if…
You will take the study medication (or placebo) by mouth every day for 12 weeks. You'll visit the clinic weekly for the first 2 weeks, then every 2 weeks during treatment, with your skin examined and assessed at each visit. After you finish the 12-week treatment period, you'll return for follow-up visits at 30, 60, and 90 days to make sure everything is going well.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States